Advice
Following an abbreviated submission
Clobetasol propionate 0.05% cutaneous foam (Clarelux) is accepted for use within NHS Scotland for short-course treatment of steroid responsive dermatoses of the scalp such as psoriasis, which do not respond satisfactorily to less potent steroids.
It offers an alternative to other scalp applications of clobetasol propionate at a similar cost (depending on the rate of application).
Download detailed advice29KB (PDF)
Medicine details
- Medicine name:
- clobetasol propionate 0.05% cutaneous foam (Clarelux)
- SMC ID:
- 280/06
- Indication:
- Steroid responsive dermatoses of the scalp
- Pharmaceutical company
- 3M Healthcare Ltd
- BNF chapter
- Skin
- Submission type
- Abbreviated
- Status
- Accepted
- Date advice published
- 10 July 2006